Turkey Rx Dry Eye Market is projected to register a steady CAGR of 4.8% in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period of 2019 to 2026.
Access Full Report at https://www.databridgemarketresearch.com/ar/reports/turkey-rx-dry-eye-market
Drivers: Turkey Rx Dry Eye Market
- Increasing prevalence of dry eye diseases
- Increasing awareness about diagnosis and treatment of the disease
Restraints:
- Stringent regulatory process
- Unmet medical needs
Opportunity:
- Development of novel technologies
Challenge:
- Increasing number of players
Market Trends:
Turkey Rx dry eye market is segmented into five notable segments which are product type, disease type, treatment type, end user and distribution channel.
- On the basis of product type, the market is segmented into emulsions, lubricant eye drops/solutions, eye ointments, nutrition supplements, autologous serum eye drops and others. In 2019, lubricant eye drops/solutions segment is expected to dominate the Turkey Rx dry eye market with largest market share because it is easier to handle by the people as compared to the emulsions, thereby increasing the preference for lubricant eye drops/solutions.
- On the basis of disease type, the market is segmented into evaporative dry eye syndrome and aqueous dry eye syndrome.
- On the basis of treatment type, the market is segmented into tear stimulators, lubricating agents, anti-inflammatory drugs, artificial tears, antibiotic drugs and others. In 2019, lubricating agents segment is expected to dominate the Turkey Rx dry eye market with largest market share because the major dry eye drugs comes in the form of solutions and are easier to handle by the patients.
- On the basis end user, the market is segmented into of home healthcare, hospitals, clinics and others.
- On the basis of distribution channel, the market is segmented into of hospital pharmacies, retail pharmacies, online pharmacies and others. In 2019, retail pharmacies segment is expected to dominate the Turkey Rx dry eye market with largest market share because these drugs are available easily in over the counter as well as in prescription based mode and the retail pharmacies act as an indirect distribution channel of dry eye drugs. The contribution of the prescribed drugs has been recorded as the highest in the retail pharmacy.
Major Players: Turkey Rx Dry Eye Market
Some of the major players operating in Turkey Rx dry eye market are Johnson & Johnson Services, Inc., ALLERGAN, Bausch & Lomb Incorporated, Teva Pharmaceutical Industries Ltd., Alcon Inc. and Novartis AG.
